LABETALOL HCL 300 MG TABLET

Labetalol Hydrochloride
$0.2045per EA
High Outlier

Strength

300 mg/1

Manufacturer

Biocon Pharma Inc.

NDC

70377006212

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LABETALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209603

On Market Since

5/27/2021

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

+0.1%

3M

-2.6%

6M

-1.1%

1Y

+2.1%

3Y

-2.2%

5Y

N/A

All

-14.7%